LOGIN
ID
PW
MemberShip
2024-10-05 18:01
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
Product
Claiming a more expensive drug than a generic
by
Kim JiEun
Nov 11, 2021 06:00am
Pharmacist A, who did not give a follow-up notice of general submission and charged for a drug that was more expensive than an alternative drug, filed a lawsuit claiming that it was an unfair disposition, but the court refused to accept it. The Seoul Northern District Court recently dismissed a claim filed by pharmacist A against the NHIS
Product
PO treatment for COVID-19 "Molnupiravir" will be released
by
Whang, byung-woo
Oct 29, 2021 05:53am
The emergence of Molnupiravir of MSD, known as the first oral treatment for COVID-19, is drawing attention to how it will affect the war against COVID-19. While it is compared to Tamiflu and is evaluated as a game changer, there are mixed views on the other side that its role may be limited due to price limitations. According to the interim
Product
Smoking cessation tx, sold out due to impurities
by
Kim JiEun
Oct 1, 2021 06:08am
According to local pharmacies on the 1st, most Bupropions used for smoking cessation treatment are sold out or lack of inventory, making it difficult to order at online malls. This out of stock is related to the recent controversy over the detection of impurities in the Varenicline. As NNV, a carcinogen, was detected in Champix (Vareniclin
Product
Take Ibuprofen after Pfizer COVID vaccine??
by
Kim JiEun
Sep 6, 2021 05:58am
Following Tylenol, the purchase of related drugs is increasing as Ibuprofen-containing painkillers have been raised to prevent side effects of COVID vaccines in certain companies. According to outpatient pharmacies on the 6th, patients who have recently been vaccinated (Pfizer vaccines) have frequently sought Ibuprofen-containing anti-infl
Product
Disturbance to secure inventory of Diovan and Exforge
by
Jung, Heung-Jun
Sep 5, 2021 08:26pm
Pharmacists suffered from inventory after six products, including Diovan and Exforge, by Novartis Korea, were announced to local pharmacies on the afternoon of the 1st. When there were concerns that impurities were detected, Novartis Korea explained that the quality was fine, but it was a lot release that was decided due to administrative del
Product
"Inhibiting ANO1 activity has effect on treating psoriasis"
by
Lee, Jeong-Hwan
Aug 5, 2021 06:02am
A study result has shown that inhibiting the activity of the Anoctamin-1 (ANO1) protein may be effective in treating psoriasis, an intractable skin disorder. The results are expected to aid further research in developing ANO1 inhibitors for the treatment of intractable diseases such as psoriasis and cancer. On the 4th, the joint research t
Product
Consult with MD about controversy over Champix?
by
Jul 7, 2021 05:53am
Concerns over the detection of carcinogens in the anti-smoking supplementary drug Champix (Varenicline), pharmacies are also making a series of inquiries. However, there are no clear guidelines for existing patients, adding to the confusion. As part of preemptive measures related to the impurity crisis, the domestic supply has been complet
Product
AZ-Pfizer vaccine mix is "confirmed safe and effective"
by
Jul 5, 2021 05:54am
With community pharmacists who have received their first vaccination of AstraZeneca¡¯s COVID-19 vaccine awaiting their second jab with the Pfizer vaccine this month, the health authorities announced that there are no safety concerns regarding the ¡®mix-and-match' of the vaccines. The authorities explained that though mild side effects were ob
Product
Sales prices have risen due to increased Tylenol demand?
by
Jung, Heung-Jun
Jun 23, 2021 05:54am
Pharmacists are upset when it is pointed out that pharmacies have raised the sales price of Tylenol due to increased demand for Tylenol. It is a misunderstanding that pharmacies are making great profits by raising prices unlike existing sales prices, which was actually a price change in some pharmacies due to differences in supply prices.
Product
Tylenol sales increased 10 times to peak in May
by
Jun 21, 2021 05:50am
Pharmacies' difficulties have reached their peak due to the surging demand for Tylenol, which is said to be "more precious than COVID-19 vaccine." This is because Tylenol has become so precious that it is rarely found in pharmacies. Then how popular was Tylenol? Analysis of POS data from 185 pharmacies showed that sales of Tylenol 500 m
1
2
3
4
5
6
7
8
9
10
>